Liminal Pharma Private Limited - Company Profile

It is a chemicals private limited company based in Kolkata, West Bengal, India, established in 2018.
2018 Kolkata, West Bengal, India Active
Last Updated:
About Liminal Pharma Private Limited

Liminal Pharma Private Limited, a active private limited company, was established on 05 September 2018 in Kolkata, West Bengal, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24239WB2018PTC227658. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.15 M.

Its leadership includes Biswarup Roy (Director), Surajit Kar (Director), Surya Sankar Dasgupta (Director). Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 31, Ghola Road Nandan Nagar, Kolkata, West Bengal, 700083.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239WB2018PTC227658

  • Registration Number

    227658

  • Incorporation Date

    05 September 2018

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.15 M

  • ROC Code

    Roc Kolkata

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.15 M
  • Company Age 7 Year, 5 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth **** %
  • Ebitda ****
  • Net Worth 59.41%
  • Total Assets **** 38.42%
Company report

Liminal Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Liminal Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Liminal Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Biswarup Roy Director 05 Sep 2018 Current
Surajit Kar Director 05 Sep 2018 Current
Surya Sankar Dasgupta Director 05 Sep 2018 Current
Rajib Ghosh Director 14 Sep 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Liminal Pharma.

Liminal Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 59.41%.

Liminal Pharma revenue growth over time
Liminal Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
38.42%
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
59.41%
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Liminal Pharma?

Unlock access to Liminal Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Liminal Pharma?

Unlock and access historical data on people associated with Liminal Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Liminal Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Liminal Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Liminal Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Liminal Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Liminal Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Kolkata. was recorded as a recent event.

  • Director Appointment

    Progress on Rajib Ghosh was appointed as a Director was appointed as a Director on 14 Sep 2020 & has been associated with this company since 5 years 5 months . was documented.

  • Director Appointment

    Progress on Biswarup Roy was appointed as a Director was appointed as a Director on 05 Sep 2018 & has been associated with this company since 7 years 5 months . was documented.

  • Director Appointment

    Surajit Kar was appointed as a Director was appointed as a Director on 05 Sep 2018 & has been associated with this company since 7 years 5 months . was recorded as a recent event.

  • Director Appointment

    Surya Sankar Dasgupta was appointed as a Director was appointed as a Director on 05 Sep 2018 & has been associated with this company since 7 years 5 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Liminal Pharma Private Limited?

The CIN of Liminal Pharma Private Limited is U24239WB2018PTC227658.

Where is Liminal Pharma Private Limited headquartered?

Liminal Pharma Private Limited is headquartered at 31, Ghola Road Nandan Nagar, Kolkata, West Bengal, 700083.

When was Liminal Pharma Private Limited incorporated?

Liminal Pharma Private Limited was incorporated on 05 September 2018.

Who are the current directors of Liminal Pharma Private Limited?

The current directors of Liminal Pharma Private Limited are

What is the primary industry of Liminal Pharma Private Limited?

The primary industry of Liminal Pharma Private Limited is Chemicals.

Is Liminal Pharma Private Limited a listed company?

Liminal Pharma Private Limited is unlisted.

What is the capital structure of Liminal Pharma Private Limited?

The authorized capital of Liminal Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.15 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available